A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
The efficacy and safety of treatment with cabozantinib in combination with nivolumab and ipilimumab in patients with previously untreated advanced renal-cell carcinoma are unknown. In this phase 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback